Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04844359

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

Conditions: Hypersensitivity Pneumonitis

Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: No
Enrollment: 137
Sponsor: National Jewish Health

Location: University of Arizona Tucson Arizona

Summary

Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of chronic hypersensitivity pneumonitis * Age 18 through 85 years. * Diagnosis of chronic hypersensitivity pneumonitis by HRCT * Able to understand and sign a written informed consent form. * Able to understand the importance of adherence to the study protocol and willing to follow all study requirements Exclusion Criteria: * Not a suitable candidate for enrollment or unlikely to comply with the requirements of this study * Known explanation for the interstitial lung disease * Clinical diagnosis of any connective tissue disease * Listed or expected to receive a lung transplant within 4 months from enrollment * Pregnant women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04844359). StuddyBuddy aggregates publicly available trial information.